"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","17/25","481/2914",1.15077571112179e-08,3.677901777989e-06,2.67110184993615e-06,"AR/CREBBP/HDAC1/MAX/SMAD3/SMAD4/STAT1/TP53/TRIM28/UBE2I/FOXO1/SREBF1/E2F4/FOS/TFDP1/TWIST1/ARID3A",17
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","17/25","499/2914",2.05469373072011e-08,3.677901777989e-06,2.67110184993615e-06,"AR/CREBBP/HDAC1/MAX/SMAD3/SMAD4/STAT1/TP53/TRIM28/UBE2I/FOXO1/SREBF1/E2F4/FOS/TFDP1/TWIST1/ARID3A",17
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","5/25","19/2914",3.26666712034071e-07,3.89822276360658e-05,2.83111150429528e-05,"HDAC1/SMAD3/SMAD4/FOXO1/SREBF1",5
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","5/25","24/2914",1.16018487580239e-06,9.57328748590756e-05,6.95266688920661e-05,"HDAC1/SMAD3/SMAD4/E2F4/TFDP1",5
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","4/25","11/2914",1.33705132484743e-06,9.57328748590756e-05,6.95266688920661e-05,"HDAC1/MAX/E2F4/TFDP1",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/25","49/2914",2.29719314781445e-06,0.000137065857819596,9.95450364052929e-05,"CREBBP/HDAC1/SMAD3/SMAD4/FOXO1/SREBF1",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","7/25","94/2914",8.68838463495072e-06,0.00042971941695008,0.000312086727393913,"PIK3R1/STAT1/STAT3/TP53/FOXO1/FOS/TWIST1",7
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","5/25","36/2914",9.60266853519733e-06,0.00042971941695008,0.000312086727393913,"HDAC1/SMAD3/SMAD4/E2F4/TFDP1",5
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","4/25","19/2914",1.49931479711215e-05,0.000596394108184609,0.000433135385832398,"HDAC1/MAX/E2F4/TFDP1",4
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/25","10/2914",6.4381921564268e-05,0.00230487279200079,0.00167392996067097,"HDAC1/E2F4/TFDP1",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/25","30/2914",9.94620105903099e-05,0.00323703634466645,0.00235092025031641,"TP53/E2F4/TFDP1/ARID3A",4
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","3/25","12/2914",0.000116700332224258,0.00348155991135702,0.00252850719819225,"PIK3R1/STAT1/STAT3",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","5/25","63/2914",0.000153179793919822,0.00421833586333049,0.00306359587839645,"HDAC1/SMAD3/SMAD4/E2F4/TFDP1",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/25","104/2914",0.000182323483860634,0.0044708738077661,0.00324700332407594,"CREBBP/HDAC1/SMAD3/STAT1/TP53/TFDP1",6
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/25","14/2914",0.000190905584081402,0.0044708738077661,0.00324700332407594,"SMAD3/SMAD4/FOXO1",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","6/25","107/2914",0.000213461713728224,0.0044708738077661,0.00324700332407594,"AR/CREBBP/HDAC1/TP53/TRIM28/UBE2I",6
"R-HSA-2990846","R-HSA-2990846","SUMOylation","6/25","109/2914",0.000236465329246167,0.0044708738077661,0.00324700332407594,"AR/CREBBP/HDAC1/TP53/TRIM28/UBE2I",6
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/25","15/2914",0.000237281012144011,0.0044708738077661,0.00324700332407594,"TP53/E2F4/TFDP1",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/25","15/2914",0.000237281012144011,0.0044708738077661,0.00324700332407594,"HDAC1/E2F4/TFDP1",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/25","20/2914",0.000577873078908381,0.01034392811246,0.00751235002580895,"HDAC1/SMAD3/SMAD4",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","5/25","86/2914",0.000664286160028962,0.0112081578369523,0.00814000289834522,"HDAC1/SMAD3/SMAD4/E2F4/TFDP1",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/25","49/2914",0.000688769476013826,0.0112081578369523,0.00814000289834522,"CASP3/STAT3/TP53/TFDP1",4
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/25","23/2914",0.00088258250695031,0.0133116979546316,0.00966771359833582,"CREBBP/TP53/TFDP1",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","7/25","194/2914",0.000892404332154076,0.0133116979546316,0.00966771359833582,"CREBBP/HDAC1/TP53/E2F4/FOS/TFDP1/ARID3A",7
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/25","53/2914",0.000930094144776344,0.0133189481531972,0.00967297910567398,"CREBBP/SMAD3/SMAD4/TP53",4
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","3/25","24/2914",0.00100296145882501,0.0138100077792059,0.0100296145882501,"PIK3R1/STAT1/STAT3",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","9/25","332/2914",0.00112360637783347,0.0148981882690512,0.010819913268026,"CASP3/PIK3R1/SMAD3/STAT1/STAT3/TP53/FOXO1/FOS/TWIST1",9
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","8/25","268/2914",0.00124208802347992,0.0158809825859219,0.0115336745037421,"CREBBP/HDAC1/PIK3R1/SMAD3/SMAD4/STAT1/STAT3/FOXO1",8
"R-HSA-69206","R-HSA-69206","G1/S Transition","4/25","60/2914",0.00148724816017272,0.0183598221152356,0.0133339490222382,"HDAC1/MAX/E2F4/TFDP1",4
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","3/25","28/2914",0.00158696965587781,0.0189378378934752,0.0137537370176077,"CREBBP/UBE2I/SREBF1",3
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","4/25","62/2914",0.00168176207783111,0.0190941743953218,0.0138672774938092,"AR/SMAD4/STAT1/TWIST1",4
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","3/25","29/2914",0.00176007752806039,0.0190941743953218,0.0138672774938092,"PIK3R1/STAT1/STAT3",3
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/25","29/2914",0.00176007752806039,0.0190941743953218,0.0138672774938092,"CREBBP/TP53/TFDP1",3
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","3/25","31/2914",0.0021407746316708,0.0225410975922984,0.0163706295363061,"PIK3R1/STAT1/STAT3",3
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/25","10/2914",0.00304941947333509,0.0295051938230801,0.0214283530558682,"STAT1/STAT3",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/25","10/2914",0.00304941947333509,0.0295051938230801,0.0214283530558682,"STAT1/STAT3",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/25","10/2914",0.00304941947333509,0.0295051938230801,0.0214283530558682,"CREBBP/FOXO1",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","3/25","37/2914",0.00357687702970256,0.0311362462405458,0.0226129162640835,"CREBBP/TRIM28/UBE2I",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/25","11/2914",0.00370750741231977,0.0311362462405458,0.0226129162640835,"STAT1/STAT3",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/25","11/2914",0.00370750741231977,0.0311362462405458,0.0226129162640835,"SMAD4/STAT3",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/25","11/2914",0.00370750741231977,0.0311362462405458,0.0226129162640835,"TP53/ARID3A",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/25","11/2914",0.00370750741231977,0.0311362462405458,0.0226129162640835,"STAT1/STAT3",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","4/25","77/2914",0.00373982845905997,0.0311362462405458,0.0226129162640835,"HDAC1/MAX/E2F4/TFDP1",4
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","9/25","397/2914",0.00401293948594335,0.0320168271212516,0.023252444278004,"CREBBP/PIK3R1/SMAD3/SMAD4/STAT3/FOXO1/SREBF1/MYOD1/TFDP1",9
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","6/25","187/2914",0.00408309563385629,0.0320168271212516,0.023252444278004,"AR/CREBBP/STAT3/TP53/FOS/TFDP1",6
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","3/25","39/2914",0.00415972755464255,0.0320168271212516,0.023252444278004,"MAX/E2F4/TFDP1",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/25","80/2914",0.00429535629350066,0.0320168271212516,0.023252444278004,"AR/SMAD3/SMAD4/TP53",4
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","6/25","189/2914",0.00430585495848013,0.0320168271212516,0.023252444278004,"AR/CREBBP/STAT3/TP53/FOS/TFDP1",6
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/25","12/2914",0.00442566882833887,0.0320168271212516,0.023252444278004,"SMAD3/SMAD4",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","3/25","40/2914",0.00447162389961615,0.0320168271212516,0.023252444278004,"MAX/E2F4/TFDP1",3
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/25","41/2914",0.00479742266746757,0.0330284099029498,0.0239871133373378,"PIK3R1/STAT1/STAT3",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/25","41/2914",0.00479742266746757,0.0330284099029498,0.0239871133373378,"PIK3R1/STAT1/STAT3",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/25","136/2914",0.00513335215817559,0.0338662035621557,0.0245955668328505,"CREBBP/HDAC1/PIK3R1/SREBF1/FOS",5
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/25","13/2914",0.0052029083684876,0.0338662035621557,0.0245955668328505,"CREBBP/SREBF1",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/25","13/2914",0.0052029083684876,0.0338662035621557,0.0245955668328505,"CREBBP/FOXO1",2
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/25","44/2914",0.00586002370274863,0.0372705292308298,0.027067982122949,"TP53/FOS/TFDP1",3
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/25","14/2914",0.00603824216588863,0.0372705292308298,0.027067982122949,"CREBBP/SREBF1",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/25","14/2914",0.00603824216588863,0.0372705292308298,0.027067982122949,"HDAC1/TP53",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","3/25","45/2914",0.0062431882617208,0.0378823965711195,0.027512355051651,"PIK3R1/STAT1/STAT3",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/25","15/2914",0.0069306977280032,0.0400191901068572,0.0290642162787231,"SMAD3/SMAD4",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/25","15/2914",0.0069306977280032,0.0400191901068572,0.0290642162787231,"CREBBP/TP53",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/25","15/2914",0.0069306977280032,0.0400191901068572,0.0290642162787231,"SMAD3/STAT3",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/25","16/2914",0.00787931382590942,0.0436472114979557,0.0316990921493533,"TP53/UBE2I",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/25","49/2914",0.00792477303733833,0.0436472114979557,0.0316990921493533,"PIK3R1/STAT1/STAT3",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/25","49/2914",0.00792477303733833,0.0436472114979557,0.0316990921493533,"CREBBP/HDAC1/FOS",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/25","17/2914",0.00888314038454034,0.0481843069343249,0.0349941893936438,"CREBBP/SMAD3",2
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","4/25","99/2914",0.00915663994013189,0.0489265238592122,0.0355332296184223,"STAT3/TP53/FOS/TFDP1",4
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/25","52/2914",0.00934615777489234,0.0492047718148744,0.0357353091392942,"CREBBP/SREBF1/CREM",3
"R-HSA-109581","R-HSA-109581","Apoptosis","4/25","101/2914",0.0098169455033241,0.0501262441950262,0.0364045348902425,"CASP3/STAT3/TP53/TFDP1",4
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","2/25","18/2914",0.00994123837387391,0.0501262441950262,0.0364045348902425,"MAX/TFDP1",2
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/25","18/2914",0.00994123837387391,0.0501262441950262,0.0364045348902425,"CREBBP/STAT1",2
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","4/25","103/2914",0.0105078638644422,0.0522474342148653,0.0379450639549301,"CASP3/STAT3/TP53/TFDP1",4
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/25","20/2914",0.0122165471035297,0.0598570071320343,0.0434715694254998,"CREBBP/SREBF1",2
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","4/25","108/2914",0.012372677451873,0.0598570071320343,0.0434715694254998,"CREBBP/HDAC1/PIK3R1/FOS",4
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","8/25","393/2914",0.0136020524622663,0.0649271304198843,0.0471537818691898,"AR/CREBBP/HDAC1/SMAD3/SMAD4/TP53/TRIM28/UBE2I",8
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/25","22/2914",0.0146979446000783,0.068335898270494,0.0496294233249398,"PIK3R1/STAT3",2
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/25","22/2914",0.0146979446000783,0.068335898270494,0.0496294233249398,"CREBBP/HDAC1",2
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","2/25","23/2914",0.0160136933708524,0.071591771817079,0.0519940242246942,"TP53/TFDP1",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/25","23/2914",0.0160136933708524,0.071591771817079,0.0519940242246942,"HDAC1/UBE2I",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/25","23/2914",0.0160136933708524,0.071591771817079,0.0519940242246942,"STAT1/STAT3",2
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","6/25","249/2914",0.0161981383161547,0.071591771817079,0.0519940242246942,"HDAC1/MAX/TP53/UBE2I/E2F4/TFDP1",6
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","4/25","119/2914",0.0172000173891759,0.072342247905838,0.0525390627249102,"CREBBP/PIK3R1/UBE2I/SREBF1",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","2/25","24/2914",0.0173783053628549,0.072342247905838,0.0525390627249102,"CREBBP/FOXO1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/25","24/2914",0.0173783053628549,0.072342247905838,0.0525390627249102,"STAT1/STAT3",2
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","2/25","24/2914",0.0173783053628549,0.072342247905838,0.0525390627249102,"AR/SMAD4",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/25","24/2914",0.0173783053628549,0.072342247905838,0.0525390627249102,"STAT1/STAT3",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/25","25/2914",0.0187909158931048,0.0773235389624311,0.0561567601403131,"CREBBP/UBE2I",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","4/25","124/2914",0.019739534030437,0.080304013442005,0.0583213505444729,"AR/SMAD3/SMAD4/TP53",4
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/25","26/2914",0.0202506704865685,0.0805526670465725,0.0585019369611979,"CREBBP/HDAC1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/25","26/2914",0.0202506704865685,0.0805526670465725,0.0585019369611979,"STAT1/TWIST1",2
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","5/25","191/2914",0.0207842482224055,0.0817666028969361,0.0593835663497301,"HDAC1/MAX/TP53/E2F4/TFDP1",5
"R-HSA-69242","R-HSA-69242","S Phase","3/25","71/2914",0.0217144008341616,0.083751693222151,0.06082525206078,"MAX/E2F4/TFDP1",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","2/25","27/2914",0.0217567247755867,0.083751693222151,0.06082525206078,"STAT3/TFDP1",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/25","28/2914",0.0233082444001797,0.0878352788975193,0.063790984674176,"SMAD3/SMAD4",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/25","28/2914",0.0233082444001797,0.0878352788975193,0.063790984674176,"AR/UBE2I",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/25","29/2914",0.0249044049092256,0.0928726766406538,0.067449429962486,"TP53/TFDP1",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/25","30/2914",0.0265443916625035,0.0969682879099617,0.0704238962474582,"STAT3/TP53",2
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","2/25","30/2914",0.0265443916625035,0.0969682879099617,0.0704238962474582,"CREBBP/TP53",2
"R-HSA-1643685","R-HSA-1643685","Disease","8/25","443/2914",0.0268424271820759,0.0970665548604362,0.0704952633064621,"CREBBP/HDAC1/PIK3R1/SMAD3/SMAD4/STAT1/STAT3/FOXO1",8
"R-HSA-391251","R-HSA-391251","Protein folding","2/25","31/2914",0.0282273997335954,0.101054091046272,0.073391239307348,"STAT3/TP53",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/25","32/2914",0.0299526338136395,0.105127871620421,0.0763498508975124,"STAT1/STAT3",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","2/25","32/2914",0.0299526338136395,0.105127871620421,0.0763498508975124,"HDAC1/TP53",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/25","34/2914",0.0335266462813442,0.11540903239155,0.0838166157033606,"TP53/UBE2I",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/25","34/2914",0.0335266462813442,0.11540903239155,0.0838166157033606,"TP53/FOS",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/25","35/2914",0.0353738812846291,0.120608090475212,0.0875924679428912,"TP53/UBE2I",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/25","37/2914",0.0391850198164328,0.132341859380028,0.0961141995497408,"CREBBP/STAT1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/25","40/2914",0.0451823047172231,0.145723108907801,0.105832425463766,"CREBBP/HDAC1",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/25","40/2914",0.0451823047172231,0.145723108907801,0.105832425463766,"CREBBP/SREBF1",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/25","40/2914",0.0451823047172231,0.145723108907801,0.105832425463766,"E2F4/TFDP1",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/25","40/2914",0.0451823047172231,0.145723108907801,0.105832425463766,"E2F4/TFDP1",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/25","40/2914",0.0451823047172231,0.145723108907801,0.105832425463766,"CREBBP/SMAD3",2
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","2/25","45/2914",0.0558783019854031,0.177731145591417,0.129078485625051,"STAT3/FOS",2
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","4/25","172/2914",0.0560994956755031,0.177731145591417,0.129078485625051,"HDAC1/PIK3R1/TP53/FOXO1",4
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/25","47/2914",0.060385798856941,0.189632596410394,0.137721997393023,"CREBBP/SREBF1",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/25","48/2914",0.0626859747893674,0.195144164996465,0.141724812567265,"CREBBP/SREBF1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/25","51/2914",0.0697644874807251,0.208130720984163,0.151156389541571,"CREBBP/HDAC1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/25","51/2914",0.0697644874807251,0.208130720984163,0.151156389541571,"CREBBP/HDAC1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/25","51/2914",0.0697644874807251,0.208130720984163,0.151156389541571,"CREBBP/HDAC1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/25","51/2914",0.0697644874807251,0.208130720984163,0.151156389541571,"CREBBP/HDAC1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/25","51/2914",0.0697644874807251,0.208130720984163,0.151156389541571,"CREBBP/HDAC1",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"TFDP1",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"UBE2I",1
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"PIK3R1",1
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"FOS",1
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"UBE2I",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"TP53",1
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","1/25","10/2914",0.0826780600904812,0.233060988286553,0.169262170263977,"PIK3R1",1
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","4/25","201/2914",0.088926362009796,0.234970226799059,0.170648768066356,"HDAC1/PIK3R1/TP53/FOXO1",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","2/25","59/2914",0.0898372859305304,0.234970226799059,0.170648768066356,"HDAC1/TP53",2
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"TFDP1",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"FOXO1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"CREBBP",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"TP53",1
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"PIK3R1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"TP53",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"PIK3R1",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/25","11/2914",0.0905751153582967,0.234970226799059,0.170648768066356,"FOXO1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","2/25","62/2914",0.0977681147040943,0.242963201340876,0.176453721644212,"PIK3R1/STAT3",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","2/25","62/2914",0.0977681147040943,0.242963201340876,0.176453721644212,"HDAC1/TP53",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/25","12/2914",0.0984068832246565,0.242963201340876,0.176453721644212,"CASP3",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/25","12/2914",0.0984068832246565,0.242963201340876,0.176453721644212,"CREBBP",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/25","12/2914",0.0984068832246565,0.242963201340876,0.176453721644212,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/25","12/2914",0.0984068832246565,0.242963201340876,0.176453721644212,"HDAC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/25","12/2914",0.0984068832246565,0.242963201340876,0.176453721644212,"HDAC1",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/25","63/2914",0.100456155357845,0.246323997384305,0.178894523239998,"PIK3R1/FOS",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/25","64/2914",0.103165516391522,0.251246631756224,0.182469620828543,"CREBBP/HDAC1",2
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/25","13/2914",0.106173881129338,0.253401662962019,0.184034727290852,"UBE2I",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/25","13/2914",0.106173881129338,0.253401662962019,0.184034727290852,"TP53",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/25","13/2914",0.106173881129338,0.253401662962019,0.184034727290852,"CREBBP",1
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"PIK3R1",1
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"PIK3R1",1
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"PIK3R1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"STAT1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/25","14/2914",0.113876622588065,0.26133224927261,0.189794370980108,"CREBBP",1
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","2/25","70/2914",0.119840386097382,0.265259701006656,0.192646710228298,"PIK3R1/STAT3",2
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"PIK3R1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"CASP3",1
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"PIK3R1",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"AR",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"HDAC1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"HDAC1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/25","15/2914",0.121515617220926,0.265259701006656,0.192646710228298,"TP53",1
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"CASP3",1
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"PIK3R1",1
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"RPS6KB1",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"PIK3R1",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"HDAC1",1
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"PIK3R1",1
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"TP53",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/25","16/2914",0.129091370780594,0.268690178717748,0.195138118621828,"PIK3R1",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"PIK3R1",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"PIK3R1",1
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"PIK3R1",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"UBE2I",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"UBE2I",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/25","17/2914",0.136604385180347,0.274311564060864,0.199220688982751,"HDAC1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/25","76/2914",0.137155782030432,0.274311564060864,0.199220688982751,"CASP3/HDAC1",2
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/25","18/2914",0.144055158521904,0.283361245883746,0.20579308360272,"PIK3R1",1
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/25","18/2914",0.144055158521904,0.283361245883746,0.20579308360272,"CASP3",1
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","1/25","18/2914",0.144055158521904,0.283361245883746,0.20579308360272,"PIK3R1",1
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"CREBBP",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"CREBBP",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"CREBBP",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"PIK3R1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"HDAC1",1
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","1/25","19/2914",0.151444185123062,0.28791884508926,0.209103071852535,"AR",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/25","81/2914",0.152001848385112,0.28791884508926,0.209103071852535,"TP53/UBE2I",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/25","82/2914",0.155011234787296,0.292073800283431,0.212120637077352,"SMAD3/STAT3",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/25","20/2914",0.158771955545143,0.292991546830727,0.212787156916171,"HDAC1",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/25","20/2914",0.158771955545143,0.292991546830727,0.212787156916171,"HDAC1",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/25","20/2914",0.158771955545143,0.292991546830727,0.212787156916171,"HDAC1",1
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","1/25","20/2914",0.158771955545143,0.292991546830727,0.212787156916171,"PIK3R1",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/25","21/2914",0.166038956620253,0.295342620901199,0.214494640877966,"CASP3",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/25","21/2914",0.166038956620253,0.295342620901199,0.214494640877966,"PIK3R1",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/25","21/2914",0.166038956620253,0.295342620901199,0.214494640877966,"UBE2I",1
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","1/25","21/2914",0.166038956620253,0.295342620901199,0.214494640877966,"PIK3R1",1
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","2/25","86/2914",0.167168825121365,0.295342620901199,0.214494640877966,"CREBBP/HDAC1",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/25","87/2914",0.170236231156731,0.295342620901199,0.214494640877966,"PIK3R1/FOS",2
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"UBE2I",1
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"PIK3R1",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"SMAD3",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"MYOD1",1
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"PIK3R1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"TP53",1
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"PIK3R1",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"HDAC1",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/25","22/2914",0.173245671478357,0.295342620901199,0.214494640877966,"SREBF1",1
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","2/25","89/2914",0.176401925925051,0.298301760460139,0.216643736647029,"PIK3R1/STAT3",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/25","23/2914",0.180392579574153,0.298301760460139,0.216643736647029,"SMAD4",1
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","1/25","23/2914",0.180392579574153,0.298301760460139,0.216643736647029,"CASP3",1
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","1/25","23/2914",0.180392579574153,0.298301760460139,0.216643736647029,"PIK3R1",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"CREBBP",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"UBE2I",1
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"PIK3R1",1
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"PIK3R1",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"TP53",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"AR",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"FOXO1",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"TP53",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"PIK3R1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"STAT1",1
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","1/25","24/2914",0.187480156713775,0.298301760460139,0.216643736647029,"FOS",1
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","1/25","25/2914",0.194508875081302,0.306371465001129,0.222504415922608,"PIK3R1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/25","25/2914",0.194508875081302,0.306371465001129,0.222504415922608,"PIK3R1",1
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","2/25","95/2914",0.195119257039825,0.306371465001129,0.222504415922608,"HDAC1/TP53",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","2/25","97/2914",0.201422227562646,0.310903253314236,0.225795658831568,"PIK3R1/FOXO1",2
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","1/25","26/2914",0.201479203265091,0.310903253314236,0.225795658831568,"PIK3R1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/25","26/2914",0.201479203265091,0.310903253314236,0.225795658831568,"CASP3",1
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","1/25","26/2914",0.201479203265091,0.310903253314236,0.225795658831568,"PIK3R1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/25","27/2914",0.208391606283919,0.314785633120856,0.228615264277717,"RPS6KB1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/25","27/2914",0.208391606283919,0.314785633120856,0.228615264277717,"CREBBP",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/25","27/2914",0.208391606283919,0.314785633120856,0.228615264277717,"CREBBP",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/25","27/2914",0.208391606283919,0.314785633120856,0.228615264277717,"TP53",1
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","1/25","27/2914",0.208391606283919,0.314785633120856,0.228615264277717,"PIK3R1",1
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","1/25","28/2914",0.215246545612946,0.321076097205978,0.233183757747359,"PIK3R1",1
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","1/25","28/2914",0.215246545612946,0.321076097205978,0.233183757747359,"PIK3R1",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/25","28/2914",0.215246545612946,0.321076097205978,0.233183757747359,"CREBBP",1
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","1/25","29/2914",0.222044479209508,0.328479022962825,0.238560184274678,"TP53",1
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","1/25","29/2914",0.222044479209508,0.328479022962825,0.238560184274678,"TP53",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/25","30/2914",0.228785861538715,0.331600560448825,0.240827222672331,"PIK3R1",1
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","1/25","30/2914",0.228785861538715,0.331600560448825,0.240827222672331,"FOS",1
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","1/25","30/2914",0.228785861538715,0.331600560448825,0.240827222672331,"FOS",1
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","1/25","30/2914",0.228785861538715,0.331600560448825,0.240827222672331,"PIK3R1",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/25","30/2914",0.228785861538715,0.331600560448825,0.240827222672331,"UBE2I",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/25","106/2914",0.230086760843757,0.332141372508327,0.241219991207165,"CASP3/HDAC1",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","4/25","289/2914",0.231270905582402,0.332509976700803,0.241487692576002,"CREBBP/PIK3R1/UBE2I/SREBF1",4
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","1/25","31/2914",0.235471143598885,0.33585127254343,0.243914332014782,"HDAC1",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/25","31/2914",0.235471143598885,0.33585127254343,0.243914332014782,"PIK3R1",1
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","2/25","108/2914",0.236508676540938,0.335992484927206,0.244016888494619,"CREBBP/HDAC1",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/25","109/2914",0.239724945904846,0.337245434688534,0.244926852008433,"CREBBP/HDAC1",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/25","109/2914",0.239724945904846,0.337245434688534,0.244926852008433,"CREBBP/HDAC1",2
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/25","32/2914",0.242100772946797,0.337245434688534,0.244926852008433,"CREBBP",1
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","1/25","32/2914",0.242100772946797,0.337245434688534,0.244926852008433,"PIK3R1",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/25","32/2914",0.242100772946797,0.337245434688534,0.244926852008433,"PIK3R1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/25","34/2914",0.255194846675531,0.350037375899771,0.254217088642292,"STAT1",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/25","34/2914",0.255194846675531,0.350037375899771,0.254217088642292,"CREBBP",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/25","34/2914",0.255194846675531,0.350037375899771,0.254217088642292,"CREBBP",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/25","34/2914",0.255194846675531,0.350037375899771,0.254217088642292,"FOXO1",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/25","35/2914",0.261660169187028,0.356176199881963,0.258675452428241,"STAT1",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/25","35/2914",0.261660169187028,0.356176199881963,0.258675452428241,"TP53",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/25","37/2914",0.274429555726914,0.369345041166298,0.268239415372172,"HDAC1",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/25","37/2914",0.274429555726914,0.369345041166298,0.268239415372172,"HDAC1",1
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","1/25","37/2914",0.274429555726914,0.369345041166298,0.268239415372172,"PIK3R1",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/25","38/2914",0.280734477905165,0.373616888810592,0.271341874555178,"CREBBP",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/25","38/2914",0.280734477905165,0.373616888810592,0.271341874555178,"UBE2I",1
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","1/25","38/2914",0.280734477905165,0.373616888810592,0.271341874555178,"PIK3R1",1
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","1/25","41/2914",0.299335240309194,0.395431793471186,0.287185101403655,"PIK3R1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/25","41/2914",0.299335240309194,0.395431793471186,0.287185101403655,"HDAC1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/25","42/2914",0.305432218726274,0.399068373372285,0.289826192951939,"PIK3R1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/25","42/2914",0.305432218726274,0.399068373372285,0.289826192951939,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/25","42/2914",0.305432218726274,0.399068373372285,0.289826192951939,"STAT1",1
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/25","43/2914",0.311478247462988,0.405488045788181,0.294488524874098,"PIK3R1",1
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/25","44/2914",0.317473734684662,0.408833082795356,0.296917881359756,"PIK3R1",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/25","44/2914",0.317473734684662,0.408833082795356,0.296917881359756,"PIK3R1",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/25","44/2914",0.317473734684662,0.408833082795356,0.296917881359756,"PIK3R1",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/25","45/2914",0.323419085427827,0.414996532556136,0.301394129789372,"PIK3R1",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/25","46/2914",0.329314701623123,0.416588915834198,0.30255060926506,"PIK3R1",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/25","46/2914",0.329314701623123,0.416588915834198,0.30255060926506,"AR",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/25","46/2914",0.329314701623123,0.416588915834198,0.30255060926506,"UBE2I",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/25","46/2914",0.329314701623123,0.416588915834198,0.30255060926506,"TP53",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/25","47/2914",0.33516098211804,0.419537173420483,0.304691801925491,"STAT1",1
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","1/25","47/2914",0.33516098211804,0.419537173420483,0.304691801925491,"STAT3",1
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","1/25","47/2914",0.33516098211804,0.419537173420483,0.304691801925491,"STAT3",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/25","48/2914",0.340958322699501,0.425306897304604,0.308882104187701,"UBE2I",1
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","1/25","49/2914",0.346707116116288,0.430976206838997,0.312999479827205,"CREBBP",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/25","50/2914",0.352407752101312,0.435041293973344,0.315951777746004,"PIK3R1",1
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","1/25","50/2914",0.352407752101312,0.435041293973344,0.315951777746004,"PIK3R1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/25","51/2914",0.358060617393724,0.438992126804634,0.318821097679343,"PIK3R1",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/25","51/2914",0.358060617393724,0.438992126804634,0.318821097679343,"PIK3R1",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","1/25","52/2914",0.363666095760876,0.442831504361883,0.321609472441591,"PIK3R1",1
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","1/25","52/2914",0.363666095760876,0.442831504361883,0.321609472441591,"PIK3R1",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/25","53/2914",0.369224568020127,0.448075916444765,0.325418263339773,"PIK3R1",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","1/25","55/2914",0.380202002864164,0.458290629715053,0.332836770184117,"PIK3R1",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/25","55/2914",0.380202002864164,0.458290629715053,0.332836770184117,"UBE2I",1
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","1/25","56/2914",0.385621712527821,0.463263668070335,0.336448474017562,"TP53",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/25","57/2914",0.390995910283876,0.468148949436881,0.339996443725109,"PIK3R1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","2/25","157/2914",0.393509877489214,0.469588453803796,0.341041893823986,"TP53/UBE2I",2
"R-HSA-202403","R-HSA-202403","TCR signaling","1/25","59/2914",0.401609232807555,0.476079819023525,0.345756293145577,"PIK3R1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/25","59/2914",0.401609232807555,0.476079819023525,0.345756293145577,"UBE2I",1
"R-HSA-450294","R-HSA-450294","MAP kinase activation","1/25","60/2914",0.406849081907314,0.480699575322833,0.349111423418817,"FOS",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/25","61/2914",0.412044867805112,0.485237048270494,0.35240679483332,"CASP3",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","1/25","62/2914",0.417196945724801,0.488093158723787,0.354481064994929,"PIK3R1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/25","62/2914",0.417196945724801,0.488093158723787,0.354481064994929,"TP53",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/25","63/2914",0.422305668150074,0.490861783109502,0.356491797789024,"UBE2I",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","1/25","63/2914",0.422305668150074,0.490861783109502,0.356491797789024,"PIK3R1",1
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","1/25","64/2914",0.427371384844655,0.495142251697043,0.359600517992266,"FOS",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/25","66/2914",0.437375186616872,0.503473687488232,0.365651281416035,"CREBBP",1
"R-HSA-69275","R-HSA-69275","G2/M Transition","1/25","66/2914",0.437375186616872,0.503473687488232,0.365651281416035,"TP53",1
"R-HSA-195721","R-HSA-195721","Signaling by WNT","2/25","172/2914",0.439480755334351,0.504275994902877,0.366233962778626,"CREBBP/HDAC1",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","1/25","68/2914",0.447211095509865,0.511506620423423,0.371485255056118,"TP53",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/25","69/2914",0.452066936202856,0.515413895415995,0.374322940804913,"PIK3R1",1
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","1/25","70/2914",0.456881813740616,0.519249807362351,0.377108798643048,"CASP3",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/25","72/2914",0.466390001896021,0.52671173715702,0.382528077264875,"PIK3R1",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/25","72/2914",0.466390001896021,0.52671173715702,0.382528077264875,"CREBBP",1
"R-HSA-109582","R-HSA-109582","Hemostasis","3/25","298/2914",0.47874207506738,0.538961204006673,0.391424338105405,"HDAC1/PIK3R1/TP53",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","1/25","78/2914",0.493965380132824,0.550902199649691,0.400096569577988,"FOS",1
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","1/25","78/2914",0.493965380132824,0.550902199649691,0.400096569577988,"FOS",1
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","1/25","78/2914",0.493965380132824,0.550902199649691,0.400096569577988,"FOS",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","1/25","80/2914",0.50284924251622,0.559068412486978,0.406027338677693,"CREBBP",1
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","1/25","83/2914",0.515894862776774,0.571796782891904,0.415271406569539,"FOS",1
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","1/25","84/2914",0.520169899311772,0.572987150626506,0.416135919449418,"FOS",1
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","1/25","84/2914",0.520169899311772,0.572987150626506,0.416135919449418,"FOS",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","1/25","85/2914",0.524408681119972,0.574502287065358,0.417236297868696,"PIK3R1",1
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","1/25","86/2914",0.52861150295525,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","1/25","86/2914",0.52861150295525,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","1/25","86/2914",0.52861150295525,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","1/25","87/2914",0.532778657278489,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","1/25","87/2914",0.532778657278489,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","1/25","87/2914",0.532778657278489,0.574502287065358,0.417236297868696,"FOS",1
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","1/25","90/2914",0.545069005746753,0.584235640890232,0.424305214054359,"FOS",1
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","1/25","90/2914",0.545069005746753,0.584235640890232,0.424305214054359,"FOS",1
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","1/25","92/2914",0.55308949397155,0.589303687029212,0.427985917954176,"PIK3R1",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","1/25","92/2914",0.55308949397155,0.589303687029212,0.427985917954176,"PIK3R1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","1/25","97/2914",0.572551222993957,0.608229489115243,0.441730913882578,"STAT1",1
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","1/25","99/2914",0.580105842488656,0.614431631985026,0.446235263452812,"PIK3R1",1
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","3/25","347/2914",0.586563466345423,0.619438704872157,0.449871685102684,"PIK3R1/STAT1/STAT3",3
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","1/25","110/2914",0.619418693286185,0.65221144763663,0.473673118395318,"FOS",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","1/25","114/2914",0.632818124502244,0.664366242146051,0.482500622787635,"TP53",1
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","1/25","127/2914",0.673309620384474,0.704809485665619,0.511872810818606,"FOS",1
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","1/25","130/2914",0.682025547516973,0.711851737641622,0.516987295493915,"AR",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","3/25","428/2914",0.733601546449774,0.763457423340172,0.554466285107388,"CREBBP/PIK3R1/FOS",3
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","1/25","153/2914",0.741815920641774,0.769768404607986,0.559049679324236,"PIK3R1",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","1/25","157/2914",0.751045733730553,0.777093562646064,0.564369626502728,"CASP3",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","1/25","165/2914",0.768564183997594,0.792927890118555,0.575869417404537,"PIK3R1",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","1/25","188/2914",0.81258425407749,0.835934376321096,0.607103178333757,"PIK3R1",1
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","1/25","202/2914",0.835315131187937,0.856856209069575,0.622297805469524,"FOXO1",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","1/25","228/2914",0.870701373760318,0.890603119446268,0.646806734793379,"AR",1
"R-HSA-422475","R-HSA-422475","Axon guidance","1/25","254/2914",0.898723758060212,0.916647023890473,0.665721302266824,"PIK3R1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","1/25","296/2914",0.932092610648003,0.947980552874958,0.688477496501366,"PIK3R1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","1/25","436/2914",0.98292429265329,0.996846733059144,0.723966901104406,"PIK3R1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","1/25","486/2914",0.98976770143154,1,0.726256983240223,"PIK3R1",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","0/25","17/2914",1,1,0.726256983240223,"",0
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","0/25","53/2914",1,1,0.726256983240223,"",0
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","0/25","45/2914",1,1,0.726256983240223,"",0
"R-HSA-5676590","R-HSA-5676590","NIK-->noncanonical NF-kB signaling","0/25","16/2914",1,1,0.726256983240223,"",0
